Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Broadly neutralizing antibodies that target HIV ENV V3 N-glycans

Broadly neutralizing antibodies that target HIV ENV V3 N-glycans

US Patent 12338277 · Granted Jun 24, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-HIV vaccine antibodies with reduced polyreactivity2025
Anti-HIV vaccine antibodies with reduced polyreactivity2025
Multivalent carriers and related vaccine compositions2025
Anti-HIV antibody 10-1074 variants2025
Human immunodeficiency virus neutralizing antibodies and methods of use thereof2025
Human immunodeficiency virus neutralizing antibodies and methods of use thereof2025
Anti-CD96 antibodies and methods of use thereof2025
Anti-CD200R1 antibodies and methods of use thereof2025
Broadly SARS-CoV-2 neutralizing monoclonal antibodies and uses thereof2025
HIV vaccine immunogens2025
HIV vaccine immunogens2025
Combination of broadly neutralizing HIV antibodies and viral inducers2025